Pennings, Elise R. A. http://orcid.org/0000-0001-7674-2148
Durmaz, Müjde http://orcid.org/0000-0002-5724-1484
Visser, Otto
Posthuma, Eduardus F. M.
Issa, Djamila E.
Chamuleau, Martine E. D. http://orcid.org/0000-0002-0123-9182
Lugtenburg, Pieternella J.
Kersten, Marie José http://orcid.org/0000-0002-8904-3802
Dinmohamed, Avinash G. http://orcid.org/0000-0002-4767-6716
Article History
Received: 26 August 2023
Revised: 8 December 2023
Accepted: 8 December 2023
First Online: 4 January 2024
Competing interests
: MEDC has a consulting/advisory role for AbbVie and Novartis and received research funding from BMS/Celgene, Gilead, and GenMAb. PJL received honoraria for advisory boards from Genmab, AbbVie, Roche, Regeneron and Incyte, has a consulting role for Y-mAbs Therapeutics, speakers’ bureau for Lilly and AbbVie, received travel support from Celgene and research funding from Takeda and Servier. MJK received honoraria from and consulting/advisory role for BMS/Celgene, Kite, a Gilead Company, Miltenyi Biotec, Novartis, and Roche, research funding from Kite, a Gilead Company, Roche, Takeda, and Celgene and travel support from Kite, a Gilead Company, Miltenyi Biotec, Novartis, and Roche (all to institution). ERAP, MD, OV, EFMP, DEI, AGD declare no conflict of interests.